Alyeska Investment Group, L.P. - Q3 2013 holdings

Add to watchlist

$2.45 Billion is the total value of Alyeska Investment Group, L.P.'s 292 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 0.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
HUBB  HUBBELL INCcl b$31,589,000
+5.8%
301,5990.0%1.29%
-11.9%
AER  AERCAP HOLDINGS NV$21,406,000
+11.5%
1,100,0000.0%0.87%
-7.3%
ICLR  ICON PLC$10,233,000
+15.5%
250,0000.0%0.42%
-3.9%
RMD  RESMED INC$9,684,000
+17.0%
183,3370.0%0.40%
-2.7%
LIFE  LIFE TECHNOLOGIES CORP COM$7,483,000
+1.1%
100,0000.0%0.31%
-15.7%
CG  CARLYLE GROUP L P$5,833,000
+0.3%
226,8000.0%0.24%
-16.5%
WMS  WMS INDS INC$5,190,000
+1.7%
200,0000.0%0.21%
-15.2%
INCY  INCYTE CORP$3,931,000
+73.4%
103,0300.0%0.16%
+45.0%
CAI  CAI INTERNATIONAL INC$3,491,000
-1.3%
150,0000.0%0.14%
-17.8%
NBHC  NATIONAL BK HLDGS CORPcl a$3,174,000
+4.3%
154,5200.0%0.13%
-12.8%
CYTK  CYTOKINETICS INC COM NEWcall$2,988,000
-34.6%
394,7360.0%0.12%
-45.5%
HZNP  HORIZON PHARMA INCcall$2,848,000
+36.2%
850,0000.0%0.12%
+12.6%
MKTG  RESPONSYS INC$1,785,000
+15.5%
108,0340.0%0.07%
-3.9%
MSTX  MAST THERAPEUTICS INCcall$1,668,000
+2.3%
1,900,0000.0%0.07%
-15.0%
LXFT  LUXOFT HLDG INC ORD SHS CL A$1,588,000
+33.1%
60,0000.0%0.06%
+10.2%
RLJE  RLJ ENTMT INCcall$1,090,000
+13.5%
200,0000.0%0.04%
-4.3%
 ORYX PETE CORP LTD COM$907,000
+4.7%
65,0000.0%0.04%
-11.9%
BIOAQ  BIOAMBER INC$711,000
-27.9%
145,0000.0%0.03%
-39.6%
BIOAQ  BIOAMBER INCcall$711,000
-27.9%
145,0000.0%0.03%
-39.6%
VELTF  VELTI PLC ST HELIER$496,000
-74.0%
1,365,2080.0%0.02%
-78.7%
SGYPQ  SYNERGY PHARMACEUTICALS DEL$457,000
+5.8%
100,0000.0%0.02%
-9.5%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2013-11-14
  • View 13F-HR/A filed 2014-02-20
  • View 13F-HR/A filed 2014-05-15
  • View 13F-HR/A filed 2015-11-19
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERCAP HOLDINGS NV38Q3 20231.7%
HONEYWELL INTL INC35Q3 20231.6%
TAKE-TWO INTERACTIVE SOFTWAR34Q3 20232.7%
LINCOLN EDL SVCS CORP34Q3 20230.2%
GENMARK DIAGNOSTICS INC31Q1 20210.3%
BUNGE LIMITED30Q2 20231.0%
COGNIZANT TECHNOLOGY SOLUTIO29Q3 20231.9%
MONSTER BEVERAGE CORP NEW29Q3 20231.3%
POPULAR INC29Q3 20230.8%
BIOMARIN PHARMACEUTICAL INC29Q3 20230.8%

View Alyeska Investment Group, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
Alyeska Investment Group, L.P. Q3 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
5:01 Acquisition Corp.Sold outFebruary 14, 202300.0%
Aris Water Solutions, Inc.Sold outFebruary 14, 202300.0%
Frazier Lifesciences Acquisition CorpSold outFebruary 14, 202300.0%
LINCOLN EDUCATIONAL SERVICES CORPFebruary 14, 20231,300,3775.0%
Omega Alpha SPACSold outFebruary 14, 202300.0%
Research Alliance Corp. IISold outFebruary 14, 202300.0%
Revolution Healthcare Acquisition Corp.Sold outFebruary 14, 202300.0%
Vy Global GrowthSold outFebruary 14, 202300.0%
Mirion Technologies, Inc.February 25, 202213,939,6337.0%
Mirion Technologies, Inc.Sold outFebruary 15, 202200.0%

View Alyeska Investment Group, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14

View Alyeska Investment Group, L.P.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been amended

Export Alyeska Investment Group, L.P.'s holdings

CSVXLS